Literature DB >> 15710999

Reoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis.

S R Demeester.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 15710999      PMCID： PMC1774404          DOI： 10.1136/gut.2004.053660

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  1 in total

1.  A comparison of multimodal therapy and surgery for esophageal adenocarcinoma.

Authors:  T N Walsh; N Noonan; D Hollywood; A Kelly; N Keeling; T P Hennessy
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245
  1 in total
  3 in total

1.  IL6 derived from cancer-associated fibroblasts promotes chemoresistance via CXCR7 in esophageal squamous cell carcinoma.

Authors:  Y Qiao; C Zhang; A Li; D Wang; Z Luo; Y Ping; B Zhou; S Liu; H Li; D Yue; Z Zhang; X Chen; Z Shen; J Lian; Y Li; S Wang; F Li; L Huang; L Wang; B Zhang; J Yu; Z Qin; Y Zhang
Journal:  Oncogene       Date:  2017-10-23       Impact factor: 9.867

2.  OTUD1 Activates Caspase-Independent and Caspase-Dependent Apoptosis by Promoting AIF Nuclear Translocation and MCL1 Degradation.

Authors:  Qingyu Luo; Xiaowei Wu; Pengfei Zhao; Yabing Nan; Wan Chang; Xiaolin Zhu; Dan Su; Zhihua Liu
Journal:  Adv Sci (Weinh)       Date:  2021-02-08       Impact factor: 16.806

3.  ARID1A prevents squamous cell carcinoma initiation and chemoresistance by antagonizing pRb/E2F1/c-Myc-mediated cancer stemness.

Authors:  Qingyu Luo; Xiaowei Wu; Wan Chang; Pengfei Zhao; Yabing Nan; Xiaolin Zhu; Jonathan P Katz; Dan Su; Zhihua Liu
Journal:  Cell Death Differ       Date:  2019-12-12       Impact factor: 15.828
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.